menu search

EVAX / Evaxion Biotech to Host Q2 2022 Corporate Update Conference Call & Webcast on August 10

Evaxion Biotech to Host Q2 2022 Corporate Update Conference Call & Webcast on August 10
COPENHAGEN, Denmark, July 29, 2022 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies, announced today that it will present its second-quarter 2022 financial results on August 10 at 8.30 a.m. EDT. Read More
Posted: Jul 29 2022, 17:46
Author Name: GlobeNewsWire
Views: 102845

EVAX News  

Evaxion (EVAX) Up on Partnership With Afrigen for Gonorrhea Jab

By Zacks Investment Research
September 21, 2023

Evaxion (EVAX) Up on Partnership With Afrigen for Gonorrhea Jab

Evaxion's (EVAX) shares gain as it collaborates with Afrigen Biologics to develop prophylactic mRNA vaccine targeting gonorrhea, based on Evaxion's ED more_horizontal

Evaxion Biotech A/S (EVAX) Q2 2023 Earnings Call Transcript

By Seeking Alpha
August 22, 2023

Evaxion Biotech A/S (EVAX) Q2 2023 Earnings Call Transcript

Evaxion Biotech A/S (EVAX) Q2 2023 Earnings Conference Call August 22, 2023 10:00 AM ET Company Participants Per Norlen - Chief Executive Officer Jesp more_horizontal

Evaxion to present a full clinical readout on two personalized cancer immunotherapies in Q2 2023

By GlobeNewsWire
December 15, 2022

Evaxion to present a full clinical readout on two personalized cancer immunotherapies in Q2 2023

COPENHAGEN, Denmark, Dec. 15, 2022 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biote more_horizontal

Evaxion Biotech A/S (EVAX) CEO Lars Wegner on Q2 2022 Results - Earnings Call Transcript

By Seeking Alpha
August 10, 2022

Evaxion Biotech A/S (EVAX) CEO Lars Wegner on Q2 2022 Results - Earnings Call Transcript

Evaxion Biotech A/S (EVAX) Q2 2022 Earnings Conference Call August 10, 2022 8:30 AM ET Company Participants Corey Davis - Managing Director, Investor more_horizontal

Evaxion Biotech to Host Q2 2022 Corporate Update Conference Call & Webcast on August 10

By GlobeNewsWire
July 29, 2022

Evaxion Biotech to Host Q2 2022 Corporate Update Conference Call & Webcast on August 10

COPENHAGEN, Denmark, July 29, 2022 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biote more_horizontal

Evaxion Biotech A/S' (EVAX) CEO Lars Wegner on Q1 2022 Results - Earnings Call Transcript

By Seeking Alpha
May 11, 2022

Evaxion Biotech A/S' (EVAX) CEO Lars Wegner on Q1 2022 Results - Earnings Call Transcript

Evaxion Biotech A/S (EVAX) Q1 2022 Earnings Conference Call May 11, 2022 8:30 AM ET Company Participants Corey Davis – LifeSci Advisors Lars Wegner more_horizontal


Search within

Pages Search Results: